Paper recorded by Signals 4 on 2026-09-18 in cs.CL. Abstract reproduced from arXiv; link to the original below.
Published 2026-09-18 on arXiv · recorded by Signals 4 on 2026-09-21
Category: cs.CL · 自然语言处理 · first seen 2026-09-21
Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely on clinical development planning (CDP) and probability of technical and regulatory success assessment to anticipate development risks, yet these decisions remain labor-intensive and subjective, requiring experts across clinical science, statistics, r